Tavlesse Europese Unie - Kroatisch - EMA (European Medicines Agency)

tavlesse

instituto grifols s.a. - Динатриевая fostamatinib - trombocitopenija - druge sistemske кровоостанавливающие - tavlesse je indiciran za liječenje kronične imunološki тромбоцитопении (ihs) u odraslih bolesnika, vatrostalne standardnim tretmanima na druge metode liječenja.

Nplate Europese Unie - Kroatisch - EMA (European Medicines Agency)

nplate

amgen europe b.v. - romiplostim - purpura, trombocitopenična, idiopatska - antihemorrhagics - adults:nplate is indicated for the treatment of primary immune thrombocytopenia  (itp) in adult patients who are refractory to other treatments (e. kortikosteroidi, imunoglobulini). paediatrics:nplate is indicated for the treatment of chronic primary immune thrombocytopenia (itp) in paediatric patients one year of age and older who are refractory to other treatments (e. kortikosteroidi, imunoglobulini).

Revolade Europese Unie - Kroatisch - EMA (European Medicines Agency)

revolade

novartis europharm limited - eltrombopag - purpura, trombocitopenična, idiopatska - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Hemlibra Europese Unie - Kroatisch - EMA (European Medicines Agency)

hemlibra

roche registration limited - emicizumab - hemofilija a - antihemorrhagics - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra mogu se koristiti u svim dobnim skupinama.

Eltrombopag Alpha-Medical 25 mg filmom obložene tablete Kroatië - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

eltrombopag alpha-medical 25 mg filmom obložene tablete

alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - eltrombopagolamin - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 25 mg eltrombopaga u obliku eltrombopagolamina

Eltrombopag Alpha-Medical 50 mg filmom obložene tablete Kroatië - Kroatisch - HALMED (Agencija za lijekove i medicinske proizvode)

eltrombopag alpha-medical 50 mg filmom obložene tablete

alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - eltrombopagolamin - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 50 mg eltrombopaga u obliku eltrombopagolamina